Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CANCER PROGRESSION AND TUMOR CELL MOTILITY
|
1 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.700 | 0 | |||||||
Breast Carcinoma
|
2793 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.050 | 1.000 | 5 | 2004 | 2018 | ||||
Malignant neoplasm of breast
|
3417 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.050 | 1.000 | 5 | 2004 | 2018 | ||||
Tumor Progression
|
72 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.030 | 1.000 | 3 | 2004 | 2015 | ||||
Malignant Neoplasms
|
1641 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.100 | 0.917 | 12 | 2005 | 2017 | ||||
Primary malignant neoplasm
|
1374 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.100 | 0.909 | 11 | 2005 | 2017 | ||||
Malignant neoplasm of prostate
|
1082 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.780 | 0.900 | 10 | 2005 | 2017 | ||||
Prostate carcinoma
|
1168 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.080 | 0.875 | 8 | 2005 | 2017 | ||||
Adenocarcinoma of lung (disorder)
|
563 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 1.000 | 2 | 2005 | 2009 | ||||
Colorectal Carcinoma
|
1962 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Node-positive breast cancer
|
3 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 1.000 | 2 | 2006 | 2015 | ||||
Bladder Neoplasm
|
281 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Carcinoma of bladder
|
309 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Carcinoma of lung
|
1204 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.030 | 1.000 | 3 | 2007 | 2017 | ||||
Malignant neoplasm of lung
|
1142 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.030 | 1.000 | 3 | 2007 | 2017 | ||||
Primary malignant neoplasm of lung
|
981 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.030 | 1.000 | 3 | 2007 | 2017 | ||||
Benign Prostatic Hyperplasia
|
91 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Carcinoma
|
103 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Progression of prostate cancer
|
7 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Neoplasms
|
1644 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.040 | 0.500 | 4 | 2010 | 2013 | ||||
Malignant neoplasm of stomach
|
615 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 0.500 | 2 | 2010 | 2013 | ||||
Squamous cell carcinoma
|
257 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 1.000 | 2 | 2010 | 2017 | ||||
Stomach Carcinoma
|
652 | 0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 | 0.020 | 0.500 | 2 | 2010 | 2013 |